Patent ID: 11926848
Assignee: ORBSEN THERAPEUTICS LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C  G

Claim 1:
2. The method of claim 1, wherein the autoimmune disease is autoimmune hepatitis; primary biliary cirrhosis (PBC); primary sclerosing cholangitis (PSC); rheumatoid arthritis; autoimmune nephritis; Wegener's granulomatosis (WG); type 1 diabetes; type 2 diabetes; uveitis; autoimmune gastritis (AIG); multiple sclerosis; inflammatory bowel diseases; Crohn's Disease; Ulcerative colitis; fistulising Crohn's disease; scleroderma; lupus (SLE); Graves' Disease; autoimmune lymphoproliferative disease (ALPS); or laminitis.